Slide 1PROTECT AF PROTECT AF trials Randomized Prospective Trial of Percutaneous LAA Closure vs Warfarin for Stroke Prevention in AF David Holmes, MD;Vivek Reddy, MD; Zoltan…

Slide 1Transcatheter LAA Occlusion Ahmed A. Khattab Cardiology Bern – Switzerland Slide 2 Patients with AF have a 5-fold higher risk of stroke >87% of strokes are thromboembolic…

Slide 1 Slide 2 Slide 3 Slide 4 Endrocrinologist Gregory Pincus (1903-1967) is best known for developing the oral contraceptive, or birth control pill. In 1960 the compound…

1.PROTECT AF Trial: Randomized Prospective Trial of Percutaneous LAA Closure vs Warfarin for Stroke Prevention in AF ACC & i2 Summit 2009 David Holmes, MD Vivek Reddy,…

1. NEUROPT HJS2073 STROKEMOHD NUH DANIAL BIN ROSDI HDD12031406 PN. FATMA HAIZUNI 2. CONTENTS Introduction Definition Risk Factor Aetiology Types Classification…

Stroke Management And Rehabilitation Prepared Mr. Maher Yassen AL Madhoon ?What is a stroke cute loss of circulation to area ofStroke is an a the brain with resultant ischaemia…

Professor David Croisdale-Appleby Chair, Standing Commission on Carers Ref: scoc care act Manchester March 25 2015 The Care Act 2014 A new agenda for carers Background to…

Slide 119 th John Friesen Conference April 23 & 24, 2009 Andrew Wister, Ph.D. Professor & Chair Department of Gerontology, SFU Slide 2  1. Are current and future…

Slide 1 Protect AF Late Breaking Trial: Randomized Prospective Trial of Percutaneous LAA Closure vs Warfarin for Stroke Prevention in AF ACC & i2 Summit 2009 Orlando,…

Slide 1 Type 2 diabetes and high blood pressure How explosive is the cocktail? Slide 2 Type 2 diabetes and high blood pressure - How explosive is the cocktail? - IEpidemiology…